[Is the progesterone test a generalizable method of screening for neoplastic and preneoplastic lesions of the endometrium?]

Bull Cancer. 1990;77(4):371-6.
[Article in French]

Abstract

A "progesterone test" has recently been proposed as a tentative method to detect early neoplastic and pre-neoplastic lesions of the uterus endometrium. At the time progesterone is stopped, a "deprivation" metrorragia demonstrates a remanent hyperoestrogenism, which represents a well-known risk factor for this type of lesion. The method has been evaluated in private practice; 389 patients were offered the test: 87% accepted. Metrorragias were observed in 28% of the cases; however, no neoplastic nor pre-neoplastic lesions could be detected in this group of patients. Moreover, one patient presented with an advanced endometrial cancer one year after a negative test. The reliability of such a test clearly needs further evaluation.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Female
  • Humans
  • Lynestrenol* / pharmacology
  • Mass Screening* / economics
  • Menopause
  • Metrorrhagia / etiology
  • Middle Aged
  • Precancerous Conditions / diagnosis*
  • Precancerous Conditions / therapy
  • Uterine Neoplasms / prevention & control*

Substances

  • Lynestrenol